Open original FDA record ↗Recall record
- FDA identifier
- Z-1239-06
- Company in FDA record
- Aksys, Ltd.
- FDA classification date
- Jul 13, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The hemodialysis device was being marketed with a modified treatment length that exceeds the treatment length for which the device was originally designed.
Source facts
- Action
- Aksys sent a Clinical Bulletin: Field Correction Recall, CB Number: 048, dated 6/26/2006, via overnight Federal Express to all clinics or patients currently using the PHD instrument. CB #048 advises patients that until field modifications to the PHD System can be performed to limit the maximum treatment time to 170 minutes, Aksys recommends that users not exceed this treatment time in the interim. Each user was requested to contact his/her clinic to discuss how this change may affect treatment options and to complete and mail an enclosed pre-paid, self-addressed receipt acknowledgement card. A revised PHD System Operatror''s Manual was issued to all PHD System users on 7/12/06, which reflects the reduction in the maximum treatment time.
- Initiated
- 2006-06-26
- Root cause
- Other
- Terminated
- 2008-05-09
- Distribution
- Nationwide (California, Connecticut, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan, Ohio, Nebraska, New Jersey, New York, Tennessee, Texas, Virginia, Washington and Wisconsin), and internationally to the United Kingdom.
- Recall number
- Z-1239-06
- Recall status
- Terminated
- CDRH record ID
- 46686
- FDA classified
- 2006-07-13
- Recall event number
- 35723